ADIPOR1

Across TCGA pan-cancer cohorts, ADIPOR1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ADIPOR1 data layer compared with 25 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher ADIPOR1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ADIPOR1 expression acts as an unfavorable survival marker.

CCRCC, LUAD, and PDAC are the cancer types where ADIPOR1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	II,III,IV	0.632	0.912	.002	10	view →
LUAD	DFS	Median	III,IV	0.429	0.854	.018	6	view →
PDAC	DFS	Quartile	II,III,IV	0.707	1.000	.026	3	view →
LSCC	DFS	Median	III,IV	0.811	1.000	.027	3	view →
HNSC	DFS	Median	III,IV	0.696	0.913	.037	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ADIPOR1–CCRCC (OS)

Open the CCRCC breakdown →